Pyrimidine-based derivative, preparation method and applications thereof

A technology of derivatives and pyrimidines, which is applied to the structure of pyrimidine derivatives and the field of preparation thereof, can solve problems such as drug resistance and patient resistance, and achieve the effects of easy operation and simple preparation process.

CN111171017AActive Publication Date: 2020-05-19TIANJIN UNIV
6 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Publication Date
2020-05-19

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a pyrimidine-based derivative, a preparation method and applications thereof. The preparation method comprises the following steps: obtaining an arylamine compound 6-phenyl-[1,2,4]triazole[4,3-a]pyridine-3-amine, and then carrying out a catalytic coupling reaction on the arylamine compound 6-phenyl-[1,2,4]triazole[4,3-a]pyridine-3-amine and 2,5-dichloro-N-(2-(isopropyl sulfonyl)phenyl)pyrimidine-4-amine to obtain the pyrimidine-based derivative. The preparation method has the advantages that the preparation process is simple and easy to operate. The prepared product hasALK inhibitory activity and can be used for preparing an ALK inhibitor.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of medicinal chemistry, and more specifically relates to a structure of a pyrimidine derivative with ALK inhibitory activity and a preparation method thereof. Background technique

[0002] Lung cancer is one of the most common malignant tumors in the world, and its mortality rate ranks first among all malignant tumors. Lung cancer can be divided into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), of which 85% belong to non-small cell lung cancer. Most non-small cell lung cancer patients are already in the middle and advanced stages when they are diagnosed, and the 5-year survival rate is very low. With the deepening of scientific research, scientists have discovered that the anaplastic lymphoma kinase (ALK) fusion gene is one of the key genes driving non-small cell lung cancer.

[0003] At present, molecular targeted therapy is the most effective and most widely used treatment method among man...

Examples

Embodiment Construction

[0030] The technical solutions of the present invention will be further described below in conjunction with specific embodiments.

[0031]

[0032] 5-Chloro-N 4 -(2-(isopropylsulfonyl)phenyl)-N 2 The preparation method of -(6-phenyl-[1,2,4]triazol[4,3-a]pyridin-3-yl)pyrimidine-2,4-diamine is shown in the following chemical reaction process.

[0033]

[0034] Step 1: Preparation of 6-phenyl-[1,2,4]triazol[4,3-a]pyridin-3-amine

[0035] Add 6-bromo-[1,2,4]triazol[4,3-a]pyridin-3-amine (1.3g, 6.00mmol), phenylboronic acid (877.9mg, 7.20mmol) successively into a 100mL three-necked flask, V (dioxane): V (water) = 15.0: 7.5, cesium carbonate (5.9g, 18.00mmol), magnetic stirring, N 2 0.5h, then add the catalyst bistriphenylphosphine palladium dichloride (421.1mg, 0.60mmol), slowly heat to 80°C, stop the reaction after 8h, add water 50mL, extract 3 times with ethyl acetate, and use anhydrous sulfuric acid It was dried over magnesium and concentrated to obtain a crude solid,...